Van't WoutJWDe Graeff-MeederERPaulLCKuisWVan FurthR. Treatment of two cases of cryptococcal meningitis with fluconazole. Scand J Infect Dis1988; 20: 193–8.
2.
BuninNCamittaB. Oral fluconazole for treatment of disseminated fungal infection (letter). Pediatr Infect Dis J1989; 8: 62.
3.
MoncinoMDGutmanLT. Severe systemic cryptococcal disease in a child: Review of prognostic indicators predicting treatment failure and an approach to maintenance therapy with oral fluconazole (letter). Pediatr Infect Dis J1990; 9: 363–8.
4.
ViscoliCCastagnolaEFioreddaFCiravegnaBBarigioneGTerragnaA. Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrob Agents Chemother1991; 35: 365–7.
5.
WormserGPOnoratoIMPremingerTJCulverDMartoneWJ. Sensitivity and specificity of blood cultures obtained through intravascular catheters. Crit Care Med1990; 18: 152–6.
6.
RogersTEGalgianiJN. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agents Chemother1986; 30: 418–22.
7.
Van't WoutJWMattieHVan FurthR. Comparison of the efficacies of amphotericin B, fluconazole and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrob Agents Chemother1989; 33: 147–51.
8.
KobayashiGSTravisSMedoffG. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatumAntimicrob Agents Chemother1986; 29: 660–2.
9.
PizzoPAWalshTJ. Fungal infections in the pediatric cancer patient. Semin Oncol1990; 17: 6–9.
10.
KorenGLauAKleinJGolasCBologa-CampeanuMSoldinS. Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr1988; 113: 559–63.
